Both in Pharmaceuticals
Kyntra Bio vs TransCode Therapeutics
Over the past year KYNB returned −28.5% and RNAZ returned −79.4%; their daily moves had a correlation of -0.02.
KYNB −28.5% RNAZ −79.4%Growth of $1, one year, split-adjusted
| Metric | KYNB | RNAZ |
|---|---|---|
| Price | $6.79 | $1.63 |
| Market cap | $27.5M | $27.6M |
| Today | −1.59% | −4.68% |
| 1 month | −15.3% | −25.2% |
| 6 months | +5.1% | −81.0% |
| Year to date | — | −76.1% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $91.3M | $7.7M |
| Dividend yield | — | — |
| Volatility (60d) | 40.3% | 98.5% |
| Short % of float | 2.6% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).